Differential Responses of Amyloid‐β 42 Aggregates to Resveratrol
Advanced Biology · 2026
DOI: 10.1002/adbi.202500586 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Biology, 2026. Verfasst von Nghia D Nguyen und 1 weiteren Autor:innen. Beteiligte Einrichtung: William A. Brookshire Department of Chemical and Biomolecular Engineering, University of Houston, Houston, Texas, USA. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Stilbenes, Peptide Fragments, Protein Aggregates. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 91 Literaturangaben. Gefördert von: Welch Foundation, Welch Center for Advanced Bioactive Materials Crystallization, NIAID NIH HHS.
Abstract (Originalsprache)
Amyloid‐β (Aβ) aggregation is targeted with small molecules as a pathway toward developing potential Alzheimer's disease (AD) therapies. Resveratrol, a natural polyphenol, has been proposed as an inhibitor of Aβ aggregation, but its mechanistic effects across distinct Aβ42 aggregates remain unresolved. To better evaluate resveratrol's potential to treat AD, here we focus on molecular‐level insights into the mechanisms that underlie its interaction with several distinct classes of Aβ42 aggregates. In contrast to published approaches that are based on monitoring the evolution of the total fibrillar mass, we employ time‐resolved in situ atomic force microscopy to explore the effects of resveratrol on Aβ42 amyloid and non‐amyloid assemblies. While data suggest a weak interaction between resveratrol and low‐molecular‐weight Aβ42 species, we also observe a concentration‐dependent reduction in fibrillization. In the presence of resveratrol, we observe a decrease in fibril thickness and end‐dependent slowing of elongation; furthermore, the fibrils exhibit reduced mechanical integrity and fragment under minimal scanning stress. Importantly, resveratrol does not affect the formation or morphology of oligomers and amorphous aggregates. These findings suggest that resveratrol selectively targets the fibril pathway while leaving oligomeric assemblies unaltered. The results provide mechanistic insights into the differential effects of small molecules on Aβ42 assemblies and establish a framework for evaluating inhibitors of aggregation with single‐aggregate resolution.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- William A. Brookshire Department of Chemical and Biomolecular Engineering, University of Houston, Houston, Texas, USA.
- Department of Chemistry, University of Houston, Houston, Texas, USA.
ORCID-Profile: Peter G Vekilov
Förderung
- Welch Foundation
- Welch Center for Advanced Bioactive Materials Crystallization
- NIAID NIH HHS
Zitieren
APA
Nguyen, N. D., & Vekilov, P. G. (2026). Differential Responses of Amyloid‐β 42 Aggregates to Resveratrol. Advanced Biology. https://doi.org/10.1002/adbi.202500586
Vancouver
Nguyen ND, Vekilov PG. Differential Responses of Amyloid‐β 42 Aggregates to Resveratrol. Advanced Biology. 2026. doi:10.1002/adbi.202500586
BibTeX
@article{Nguyen2026,
author = {Nguyen, Nghia D and Vekilov, Peter G},
title = {Differential Responses of Amyloid‐β 42 Aggregates to Resveratrol},
journal = {Advanced Biology},
year = {2026},
doi = {10.1002/adbi.202500586}
}
EUVIMED